Peptide record

TPDB00752

ACE inhibitor ACE inhibitors Antihypertensive Antioxidant Neuropeptide standard
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB00752
ACE inhibitor
ACE inhibitors Antihypertensive Antioxidant Neuropeptide
Cardiometabolic peptides Neuroactive peptides Functional / health-promoting peptides
FermFooDB Peptipedia AHTPDB AHTpin AnOxPePred - 1.0 AODB Multi-AOP
standard
No
A 5-aa standard-residue multi-activity (ACE inhibitors, Antihypertensive, Antioxidant, and other sources) peptide sequence curated from FermFooDB, Peptipedia, AHTPDB, and other sources, with an available 3D structural model.
Sequence
HLPLP
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C28H45N7O6
ARNDCEQGIKMFSTWYV
LP
575.71
7.85
1
0
2
+0
-1.04
0.240
156.00
Mammalian: 3.5 hour Yeast: 10 min E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
1
H
0
I
2
L
0
K
0
M
0
F
2
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 1 I: 0 L: 2 K: 0 M: 0 F: 0 P: 2 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
5 reviewed residue count
C28H45N7O6 sequence-only estimate (linear, free termini)
575.71 sequence-only estimate (linear, free termini)
7.85 sequence-only estimate (linear, free termini)
+0 sequence-only estimate (linear, free termini)
-1.04 sequence-only estimate (linear, free termini)
0.240 sequence-only estimate (linear, free termini)
575.6984 Activity
575.3421 Activity
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
41.00 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001) antihypertensive peptide in vivo in rats.
ACE inhibitor
ah

Source & Reference

FermFooDB
Kohmura M., Nio N., Kubo K., Minoshima Y., Munekata E., Ariyoshi Y.
Inhibition of angiotensin-converting enzyme by synthetic peptides of human beta-casein. Agric. Biol. Chem., 53(8), 2107-2114 (1989)
1989
Journal

Other

5
BIOPEP-UWM database of bioactive peptides SMILES: [H][C@](N)(Cc1cnc[nH]1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1CCC[C@@]1([H])C(=O)N[C@@]([H])(CC(C)C)C(=O)N1CCC[C@@]1([H])C(O)=O InChI=1S/C28H45N7O6/c1-16(2)11-20(32-24(36)19(29)13-18-14-30-15-31-18)26(38)34-9-5-7-22(34)25(37)33-21(12-17(3)4)27(39)35-10-6-8-23(35)28(40)41/h14-17,19-23H,5-13,29H2,1-4H3,(H,30,31)(H,32,36)(H,33,37)(H,40,41)/t19-,20-,21-,22-,23-/m0/s1 InChIKey: FGQVFEKPNYGHEX-VUBDRERZSA-N Information concerning Angiotensin-Converting Enzyme (ACE) is available in MEROPS database of proteolytic enzymes (http://merops.sanger.ac.uk/) ID: M02-001 Another value of peptide IC50 (EC50) = 21 uM. Hernández-Ledesma B., Quirós A., Amigo L., Recio I., 2007, Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin. Int. Dairy J., 17, 42-49 Antihypertensive activity in vivo in rats: Sanchez-Rivera L., Ferreira Santos P., Miralles B., Carron R., Montero J., Recio I., 2016, Peptide fragments from beta-casein f(134–138), HLPLP, generated by the action of rat blood plasma peptidases show potent antihypertensive activity. Food Res. Int., 88, 348-353
Evidence 2 Activity

Activity

IC50
Antihypertensive
41.00 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001) antihypertensive peptide in vivo in rats.
ACE inhibitor
ah

Source & Reference

AHTPDB FermFooDB
Kohmura M., Nio N., Kubo K., Minoshima Y., Munekata E., Ariyoshi Y.
Inhibition of angiotensin-converting enzyme by synthetic peptides of human beta-casein. Agric. Biol. Chem., 53(8), 2107-2114 (1989)
1989
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
5
BIOPEP-UWM database of bioactive peptides SMILES: [H][C@](N)(Cc1cnc[nH]1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1CCC[C@@]1([H])C(=O)N[C@@]([H])(CC(C)C)C(=O)N1CCC[C@@]1([H])C(O)=O InChI=1S/C28H45N7O6/c1-16(2)11-20(32-24(36)19(29)13-18-14-30-15-31-18)26(38)34-9-5-7-22(34)25(37)33-21(12-17(3)4)27(39)35-10-6-8-23(35)28(40)41/h14-17,19-23H,5-13,29H2,1-4H3,(H,30,31)(H,32,36)(H,33,37)(H,40,41)/t19-,20-,21-,22-,23-/m0/s1 InChIKey: FGQVFEKPNYGHEX-VUBDRERZSA-N Information concerning Angiotensin-Converting Enzyme (ACE) is available in MEROPS database of proteolytic enzymes (http://merops.sanger.ac.uk/) ID: M02-001 Another value of peptide IC50 (EC50) = 21 uM. Hernández-Ledesma B., Quirós A., Amigo L., Recio I., 2007, Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin. Int. Dairy J., 17, 42-49 Antihypertensive activity in vivo in rats: Sanchez-Rivera L., Ferreira Santos P., Miralles B., Carron R., Montero J., Recio I., 2016, Peptide fragments from beta-casein f(134–138), HLPLP, generated by the action of rat blood plasma peptidases show potent antihypertensive activity. Food Res. Int., 88, 348-353
Evidence 3 Activity

Activity

Antioxidative activity
Antioxidant

Source & Reference

AODB FermFooDB
DFBP
Additional Detail Fields 1 fields
5